期刊文献+

HPV分型与液基细胞学联合检测在宫颈癌及癌前病变筛查中的效能 被引量:7

Efficacy of combined detection of HPV typing and liquid-based cytology in screening for cervical cancer and precancerous lesions
下载PDF
导出
摘要 目的探讨人乳头状瘤病毒(HPV)分型与液基细胞学联合检测在宫颈癌及癌前病变筛查中的效能。方法选取2017年1月至2019年12月收治的接受HPV分型与液基细胞学筛查宫颈病变的女性60例进行观察,所有患者均经HPV分型、液基细胞学检测、病理学检查,以病理学结果为金标准,比较分析HPV分型、液基细胞学单独与联合检测在宫颈癌及癌前病变筛查中的效能。结果60例患者经病理检查显示,宫颈癌8例,CIN 1级13例,CIN 2级14例,CIN 3级13例,正常12例;HPV分型检测示真阳性40例,真阴性11例;液基细胞学检测示真阳性30例,真阴性11例;HPV分型联合液基细胞学检测示真阳性47例,真阴性12例。HPV分型联合液基细胞学检测的灵敏度、准确度、阴性预测值明显高于单独HPV分型、液基细胞学检测(P<0.05)。宫颈癌及癌前病变患者的HPV分型阳性率及液基细胞学检测阳性率均显著高于正常组(P<0.05)。结论临床在宫颈癌及癌前病变筛查中采用HPV分型与液基细胞学联合检测有助于提高诊断效能,宫颈癌及癌前病变患者的HPV分型阳性率及液基细胞学检测阳性率均明显高于正常者。 Objective To explore the efficacy of combined detection of human papilloma virus(HPV)typing and liquid-based cytology in screening for cervical cancer and precancerous lesions.Methods Sixty women undergoing HPV typing and liquid-based cytology screening for cervical lesions from January 2017 to December 2019 were selected for observation.The women were diagnosed by HPV typing,liquid-based cytology and pathological examination.With the pathological results as the gold standard,the efficacy of HPV typing,liquid-based cytology alone and combined detection in the screening of cervical cancer and precancerous lesions were compared and analyzed.Results Pathological examination of 60 patients showed 8 cases of cervical cancer,13 cases of CIN 1 grade,14 cases of CIN 2 grade,13 cases of CIN 3 grade,and 12 normal cases;HPV typing showed 40 cases of true positive and 11 cases of true negative;liquid-based cytology showed 30 cases of frue positive,and 11 cases of true negative;combined detection of HPV typing and liquid-based cytology showed 47 cases of true positive,and 12 cases of true negative.The sensitivity,accuracy and negative predictive value of HPV typing combined with liquid-based cytology were significantly higher than those of HPV typing and liquid-based cytology alone(P<0.05).The positive rates of HPV typing and liquid-based cytology in patients with cervical cancer and precancerous lesions were significantly higher than those in the normal group(P<0.05).Conclusion The clinical use of HPV typing and liquid-based cytology in the screening of cervical cancer and precancerous lesions can help improve the diagnostic efficiency.The positive rates of HPV typing and liquid-based cytology in patients with cervical cancer and precancerous lesions were significantly higher than those in normal subjects.
作者 张文洁 吴美娟 ZHANG Wenjie;WU Meijuan(the Fourth People's Hospital of Yixing,Yixing 214200,China)
出处 《临床医学研究与实践》 2021年第31期105-107,共3页 Clinical Research and Practice
关键词 HPV分型 液基细胞学 联合检测 宫颈癌 癌前病变 HPV typing liquid-based cytology combined detection cervical cancer precancerous lesions
  • 相关文献

参考文献15

二级参考文献113

  • 1Weihong Li,Yu Guo,Haiyan Niu,Song Jin,Li Wang.Application of TruScreen in detecting ASCUS patients[J].Asian Pacific Journal of Tropical Medicine,2011,4(8):669-671. 被引量:2
  • 2钱德英,岑坚敏,王丁,曾仁海,林爱华,舒焰红,洪淡华,黄志宏.高危型人乳头状瘤病毒DNA检测与细胞学联合检查对子宫颈癌前病变筛查的研究[J].中华妇产科杂志,2006,41(1):34-37. 被引量:168
  • 3Mufioz N, Bosch FX, de Sanjose S, et al. Epidemiologic clas- sification of human papillomavirus types associated with cervi- cal cancer [ J] .N Eng J Med, 2003, 348 (6): 518 -527.
  • 4Dajani YF, Maayta UM, Abu - Ghosh YR. Cervical intraepi- thelial neoplasia in Jordan : a ten year retrospective cytoepide- miologic study [J] .Ann Saudi Med, 1995, 15 (4): 354 - 357.
  • 5van den Akker- van Marie ME, van Ballegooijen M, Ro- zendaal L, et al. Extended duration of the detectable stage by adding HPV test in cervical cancer screening [ J ] . Br J Cancer, 2003, 89 (10) : 1830 - 1833.
  • 6Cui H,Li T,Wang L,Su Y,et al.Dioscorea bulbifera polysaccharide and cyclophosphamide combination enhances anti-cervical cancer effect and attenuates immunosuppression and oxidative stress in mice[J].Sci Rep,2016,5:19185.
  • 7Bountris P,Haritou M,Pouliakis A,et al.A decision support system based on an ensemble of random forests for improving the management of women with abnormal findings at cervical cancer screening[J].Conf Proc IEEE Eng Med Biol Soc,2015,2015:8151-6.
  • 8Monsonego J,Cox JT,Behrens C,et al.Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S.screening population:data from the ATHENA trial[J].Gynecol Oncol,2015,137(1):47-54.
  • 9Zhang R,He YF,Chen M,et al.Diagnosis of 25 genotypes of human papillomaviruses for their physical statuses in cervical precancerous/cancerous lesions:a comparison of E2/E6E7 ratio-based vs.multiple E1-L1/E6E7 ratio-based detection techniques[J].J Transl Med,2014,12:282.
  • 10Guo X,Qiu L,Wang Y,et al.A randomized open-label clinical trial of an anti-HPV biological dressing(JB01-BD)administered intravaginally to treat high-risk HPV infection[J].Microbes Infect,2016,18(2):148-152.

共引文献431

同被引文献60

引证文献7

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部